Concord Drugs share news and announcements
BSE: 538965Pharmaceuticals & BiotechnologySmall Cap
Last close ₹68.06down ₹0.94 (1.36%)
Share price at the BSE close on 23 Oct 2026. Previous close ₹69.00.
52-week range of traded prices to 23 Oct 2026
₹61.00Low, 23 Oct 2025₹92.52High, 13 Nov 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹90 Cr3,001st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 10 Aug 2026
- 43.7
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 10 Aug 2026
- 5.0%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 10 Aug 2026
- 7.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 27 May 2026
- 0.28
- Volume, BSEVolume. Shares traded on the last trading day.
- 1,703
Concord Drugs routine notices
110 filed, newest first. Page 2 of 3.
Jun 2023
30 Jun · Routine
May 2023
Apr 2023
Mar 2023
Feb 2023
Jan 2023
12 Jan · Routine
Dec 2022
Oct 2022
19 Oct · Routine
Sep 2022
30 Sep · Routine
Aug 2022
Jul 2022
Jun 2022
May 2022
Apr 2022
Mar 2022
Jan 2022
Dec 2021
30 Dec · Routine
Oct 2021
Sep 2021
28 Sep · Routine
Jul 2021
1 Jul · Routine
Apr 2021
Mar 2021
Jan 2021
Dec 2020
Oct 2020
Sep 2020
Jul 2020
Jun 2020
30 Jun · Routine
May 2020
Mar 2020
Jan 2020
Dec 2019
Oct 2019
26 Oct · Routine
Sep 2019
26 Sep · Routine
16 Sep · Routine
Jun 2019
May 2019
Apr 2019
Jan 2019
Nov 2018
5 Nov · Routine
Aug 2018
May 2018
Feb 2018
Jan 2018
Dec 2017
1 Dec · Routine
Aug 2017